Medial Earlysign

Biotech & Life Sciences · Kfar Malal, Israel · Founded 2009

Healthcare company using AI to predict and prevent high-risk diseases MoreLess

Medial EarlySign, founded in 2009 by machine learning pioneers, specializes in analyzing clinical data to detect early signs of serious diseases such as cancer. The company collaborates with leading health systems in the United States, Europe, and Asia, leveraging a wide array of clinical data including claims and advanced diagnostics. Medial EarlySign's technology organizes and analyzes clinical data using machine learning and artificial intelligence, transforming it into actionable clinical insights. The company serves a diverse range of clients including healthcare providers, labs, payers, diagnostics, pharma, and life sciences sectors. Operating in the healthcare market, Medial EarlySign's business model focuses on providing advanced data analytics solutions to improve early disease detection and patient outcomes. Revenue is generated through partnerships and service agreements with healthcare organizations.

Keywords: AI, machine learning, clinical data, early detection, healthcare, diagnostics, data analytics, chronic diseases, medical insights, health systems.

Valuation $100–500M

Headcount <100

Total funding $50–100M

Unlock exact values

Company overview

Medial Earlysign company information

The essential company record, classifications and operating signals in one place.

Status: Operational
Founded: 2009
Headquarters: Kfar Malal, Israel
Employees: 8
Open positions: None listed
Dealroom signal: 62.8

Website ↗LinkedIn ↗X ↗

sub industryBioTechnologysub industryMedical DevicessectorIntellectual PropertyindustryHealthsectorRisk ManagementsectorData AnalyticssectorPredictive AnalyticssectorBiotechnologysectorOncologysectorDrug DevelopmentsectorClinicalsectorCore AIsectorPrecision MedicinesectorTech for Hospitals and Clinics

Valuation & funding

Medial Earlysign funding history

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Mar 2018	$30M	$120M	Marius Nacht · Horizons Ventures · Nir Kalkstein · aMoon Fund	↗
SERIES AOther financing	Jun 2013	$20M	$80M	Horizon Ventures	—

Showing 2 recorded eventsUnlock the complete deal history →

Growth signals

Medial Earlysign website traffic

Latest recorded traffic for Medial Earlysign is 100 monthly website visits, down 47.4% over the last three months. Medial Earlysign's team declined 20% over the past year.

Latest monthly visits100 3-month web change-47.4% 1-year team growth-20%

Monthly website visits100 observations · Apr 2016–Sep 2025

Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Medial Earlysign compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OPOptellumDeveloping an artificial intelligence software platform to support clinicians in lung cancer nodule management	Oxford, United Kingdom	Operational	51	$30M	$23M
ETEmedgene technologiesEmedgene uses AI to automatically interpret genetic tests, so that health organizations can scale personalized care to wider populations	Palo Alto, United States	Acquired
SGSophia GeneticsHelps clinicians and physicians predict genetic diseases better	Saint-Sulpice, Switzerland	Operational
QUQuibimProducer of whole body radiological image analysis based on Artificial Intelligence	Valencia, Spain	Operational
HUHumaProvides a digital health platform used for predictive care and research	London, United Kingdom	Operational
LILifebitEmpowers therapeutic leaders and pioneers in precision medicine on how to access and analyse siloed biomedical data	London, United Kingdom	Operational
ENEnliticA modern machine learning company dedicated to revolutionizing diagnostic healthcare	San Francisco, United States	Operational
MIMindPeakMindPeak automates visual diagnosis, making microscopical analysis more accessible to support in accurate cancer diagnoses	Hamburg, Germany	Operational

Showing 8 of the closest matchesCompare every metric →

Talent graph

Medial Earlysign's talent

Book a demo to see the people

Team profiled 17 named & role-tagged

Founders /100 quality score

Key operators 3 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on Medial Earlysign's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 5 investors entered at this stage

Horizon Ventures

aMoon Fund

Marius Nacht

Horizons Ventures

Nir Kalkstein

Global footprint

Where Medial Earlysign has talent and traffic

Workforce by country

3 countries with
team presence

🇮🇱 Israel66.7%

🇭🇰 Hong Kong16.7%

🇺🇸 United States16.7%

3 countries shown

In the news

Latest news about Medial Earlysign

Recent press, funding announcements, and product moves mentioning Medial Earlysign — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Medial Earlysign

An AI-synthesized read of the highest-engagement posts about Medial Earlysign on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Medial Earlysign’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.